Odenwald, T and Nakagawa, K and Hadtstein, C and Roesch, F and Gohlke, P and Ritz, E and Schaefer, F and Schmitt, CP (2006) Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats. J AM SOC NEPHROL , 17 (3) 655 - 662. 10.1681/ASN.2005090914.
Full text not available from this repository.
A previous study in subtotally nephrectomized (SNX) rats suggested beneficial effects of the calcimimetic R-568 beyond the control of mineral metabolism. This study analyzed potential blood pressure (BP)-lowering effects of R-568. Male Sprague-Dawley rats received two-stage subtotal nephrectomy or sham operation. Telemetry devices were inserted into the abdominal aorta, and BP was measured every 5 min. R-568 (20 mg/kg per d) or solvent was infused for 4 wk followed by once-daily subcutaneous injections for 2 wk. Total body sodium was measured by neutron activation analysis. The uremia-induced increase of mean arterial pressure from baseline to day 42 in SNX solvent rats (103 +/- 5 to 128 +/- 14 mmHg, P = 0.006) was attenuated by R-568 (104 +/- 5 to 111 +/- 8 mmHg; P < 0.0001 for difference of slopes). The circadian rhythm was abrogated in SNX rats and not restored by R-568. In sham-operated rats, R-568 had only a minor transient antihypertensive effect. R-568 injection induced a transient rise of mean arterial pressure by 23 4 and 26 10 mmHg in sham and SNX rats but only by 9 3 and 10 5 mmHg in solvent-treated rats (P < 0.01 versus baseline and solvent versus R-568). Plasma angiotensin-converting enzyme activity and aldosterone levels were similar; food intake and physical activity did not differ throughout the study. In healthy rats, total body sodium was higher after 14 d of R-568 compared with solvent infusion (37.1 +/- 4 versus 32.5 +/- 1.4 mmol/kg; P = 0.01). The calcimimetic R-568 causes an initial BP increase in sham-operated and uremic rats, which in uremic rats is followed by a marked and sustained antihypertensive effect.
|Title:||Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats|
|Keywords:||SPONTANEOUSLY HYPERTENSIVE-RATS, CALCIUM-SENSING RECEPTOR, NERVE CA2+ RECEPTOR, SECONDARY HYPERPARATHYROIDISM, PARATHYROID-HORMONE, RENAL-FAILURE, HEMODIALYSIS, ARTERIES, CINACALCET, AGENT|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science|
Archive Staff Only: edit this record